SOX9 and schistosomiasis: Alongside our previous studies, this suggests a pro-fibrotic role for SOX9 across injury immunotypes and indicates factors downstream of SOX9 may yield therapeutic targets against fibrosis and to promote corrective repair during schistosomiasis and in other fibrotic diseases.